Delayed release oral pharmaceutical dosage forms comprising MGBG
US8858991B2 · kind B2 · utility
8Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2012 |
| Grant date | Oct 14, 2014 |
| Priority date | — |
| Expiry date | Jan 19, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C251/78
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.